Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:ATCCode |
C01EB25
|
| gptkbp:CASNumber |
873697-71-3
|
| gptkbp:developedBy |
gptkb:Amgen
gptkb:Cytokinetics |
| gptkbp:hasMolecularFormula |
C25H30N6O3S
|
| https://www.w3.org/2000/01/rdf-schema#label |
omecamtiv mecarbil
|
| gptkbp:IUPACName |
N-(9-(2-(4-(pyridin-4-yl)piperazin-1-yl)ethyl)-9H-fluoren-9-yl)thiophene-2-carboxamide
|
| gptkbp:mechanismOfAction |
cardiac myosin activator
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2105727
25154894 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:status |
investigational
|
| gptkbp:synonym |
gptkb:AMG_423
gptkb:CK-1827452 |
| gptkbp:target |
cardiac myosin
|
| gptkbp:UNII |
6Z5B6HVF6O
|
| gptkbp:usedFor |
heart failure
|
| gptkbp:bfsParent |
gptkb:Cytokinetics
|
| gptkbp:bfsLayer |
6
|